Anna B. Fishbein, MD, FAAAAI, discusses the new educational course developed by the AAAAI that addresses the latest information surrounding the diagnosis and management of atopic dermatitis. This course provides important insights on new therapeutic agents, including biologics and JAK inhibitors, and how to discuss these treatment options with your patients.